miR-106b-5p and miR-17-5p could predict recurrence and progression in breast ductal carcinoma in situ based on the transforming growth factor-beta pathway
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
miR-106b-5p and miR-17-5p could predict recurrence and progression in breast ductal carcinoma in situ based on the transforming growth factor-beta pathway
Authors
Keywords
DCIS, Recurrence, miR-106b, miR-17, TGF-β
Journal
BREAST CANCER RESEARCH AND TREATMENT
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2019-04-15
DOI
10.1007/s10549-019-05192-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- miRNAs as Biomarkers for Predicting the Progression of Ductal Carcinoma in Situ
- (2018) Bethany N. Hannafon et al. AMERICAN JOURNAL OF PATHOLOGY
- miR-17 as a diagnostic biomarker regulates cell proliferation in breast cancer
- (2017) Fangliang Yang et al. OncoTargets and Therapy
- Subtype-specific micro-RNA expression signatures in breast cancer progression
- (2016) Vilde D. Haakensen et al. INTERNATIONAL JOURNAL OF CANCER
- The Basic Facts of Korean Breast Cancer in 2013: Results of a Nationwide Survey and Breast Cancer Registry Database
- (2016) Sun Young Min et al. Journal of Breast Cancer
- Crosstalk between TGF-β signaling and miRNAs in breast cancer metastasis
- (2016) Wei Chen et al. TUMOR BIOLOGY
- MiR-17-5p regulates cell proliferation and migration by targeting transforming growth factor-β receptor 2 in gastric cancer
- (2016) Yanjun Qu et al. Oncotarget
- Crucial microRNAs and genes of human primary breast cancer explored by microRNA-mRNA integrated analysis
- (2015) Yang Yang et al. TUMOR BIOLOGY
- Effect of Radiotherapy After Breast-Conserving Surgery for Ductal Carcinoma in Situ: 20 Years Follow-Up in the Randomized SweDCIS Trial
- (2014) Fredrik Wärnberg et al. JOURNAL OF CLINICAL ONCOLOGY
- miR-106b-25/miR-17-92clusters: Polycistrons with oncogenic roles in hepatocellular carcinoma
- (2014) Weiqi Tan WORLD JOURNAL OF GASTROENTEROLOGY
- Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
- (2013) Antonio C. Wolff et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- The miR-17/92 cluster: a comprehensive update on its genomics, genetics, functions and increasingly important and numerous roles in health and disease
- (2013) E Mogilyansky et al. CELL DEATH AND DIFFERENTIATION
- Breast-Conserving Treatment With or Without Radiotherapy in Ductal Carcinoma In Situ: 15-Year Recurrence Rates and Outcome After a Recurrence, From the EORTC 10853 Randomized Phase III Trial
- (2013) Mila Donker et al. JOURNAL OF CLINICAL ONCOLOGY
- MiR-106b expression determines the proliferation paradox of TGF-β in breast cancer cells
- (2013) C Gong et al. ONCOGENE
- Role of Deregulated microRNAs in Breast Cancer Progression Using FFPE Tissue
- (2013) Liang Chen et al. PLoS One
- Targeting the TGFβ signalling pathway in disease
- (2012) Rosemary J. Akhurst et al. NATURE REVIEWS DRUG DISCOVERY
- The miR-106b-25 cluster targets Smad7, activates TGF-β signaling and induces EMT and tumor initiating cell characteristics downstream of Six1 in human breast cancer
- (2012) A L Smith et al. ONCOGENE
- Crosstalk between TGF-β signaling and the microRNA machinery
- (2012) Henriett Butz et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- microRNA-Associated Progression Pathways and Potential Therapeutic Targets Identified by Integrated mRNA and microRNA Expression Profiling in Breast Cancer
- (2011) F. M. Buffa et al. CANCER RESEARCH
- Long-Term Outcomes of Invasive Ipsilateral Breast Tumor Recurrences After Lumpectomy in NSABP B-17 and B-24 Randomized Clinical Trials for DCIS
- (2011) I. L. Wapnir et al. JNCI-Journal of the National Cancer Institute
- miRNA-mRNA Integrated Analysis Reveals Roles for miRNAs in Primary Breast Tumors
- (2011) Espen Enerly et al. PLoS One
- miR-17-5p promotes human breast cancer cell migration and invasion through suppression of HBP1
- (2010) Hongling Li et al. BREAST CANCER RESEARCH AND TREATMENT
- Ductal Carcinoma In Situ of the Breast: A Systematic Review of Incidence, Treatment, and Outcomes
- (2010) B. A. Virnig et al. JNCI-Journal of the National Cancer Institute
- Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial
- (2010) Jack Cuzick et al. LANCET ONCOLOGY
- microRNA 17/20 inhibits cellular invasion and tumor metastasis in breast cancer by heterotypic signaling
- (2010) Z. Yu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cellular context-dependent “colors” of transforming growth factor-β signaling
- (2009) Hiroaki Ikushima et al. CANCER SCIENCE
- Causes and consequences of microRNA dysregulation in cancer
- (2009) Carlo M. Croce NATURE REVIEWS GENETICS
- miRiad Roles for the miR-17-92 Cluster in Development and Disease
- (2008) Joshua T. Mendell CELL
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search